These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
271 related items for PubMed ID: 25056757
1. In vitro evaluation of the effects of perfluorooctanesulfonic acid (PFOS) and perfluorooctanoic acid (PFOA) on IL-2 production in human T-cells. Midgett K, Peden-Adams MM, Gilkeson GS, Kamen DL. J Appl Toxicol; 2015 May; 35(5):459-65. PubMed ID: 25056757 [Abstract] [Full Text] [Related]
2. In vitro evaluation of the immunotoxic potential of perfluorinated compounds (PFCs). Corsini E, Avogadro A, Galbiati V, dell'Agli M, Marinovich M, Galli CL, Germolec DR. Toxicol Appl Pharmacol; 2011 Jan 15; 250(2):108-16. PubMed ID: 21075133 [Abstract] [Full Text] [Related]
4. Perfluorinated chemicals, PFOS and PFOA, enhance the estrogenic effects of 17β-estradiol in T47D human breast cancer cells. Sonthithai P, Suriyo T, Thiantanawat A, Watcharasit P, Ruchirawat M, Satayavivad J. J Appl Toxicol; 2016 Jun 15; 36(6):790-801. PubMed ID: 26234195 [Abstract] [Full Text] [Related]
6. Transcription of genes involved in fat metabolism in chicken embryos exposed to the peroxisome proliferator-activated receptor alpha (PPARα) agonist GW7647 or to perfluorooctane sulfonate (PFOS) or perfluorooctanoic acid (PFOA). Strömqvist M, Olsson JA, Kärrman A, Brunström B. Comp Biochem Physiol C Toxicol Pharmacol; 2012 Jun 15; 156(1):29-36. PubMed ID: 22465071 [Abstract] [Full Text] [Related]
8. Perfluorooctanesulfonate (PFOS) and perfluorooctanoic acid (PFOA) modify in vitro mitogen- and antigen-induced human peripheral blood mononuclear cell (PBMC) responses. Kasten-Jolly J, Lawrence DA. J Toxicol Environ Health A; 2022 Sep 02; 85(17):715-737. PubMed ID: 35611390 [Abstract] [Full Text] [Related]
9. Gene expression profiling in the liver and lung of perfluorooctane sulfonate-exposed mouse fetuses: comparison to changes induced by exposure to perfluorooctanoic acid. Rosen MB, Schmid JE, Das KP, Wood CR, Zehr RD, Lau C. Reprod Toxicol; 2009 Jun 02; 27(3-4):278-288. PubMed ID: 19429403 [Abstract] [Full Text] [Related]
10. Developmental exposure to perfluorooctane sulfonate (PFOS) and perfluorooctanoic acid (PFOA) selectively decreases brain dopamine levels in Northern leopard frogs. Foguth RM, Flynn RW, de Perre C, Iacchetta M, Lee LS, Sepúlveda MS, Cannon JR. Toxicol Appl Pharmacol; 2019 Aug 15; 377():114623. PubMed ID: 31195004 [Abstract] [Full Text] [Related]
11. The role of hepatocyte nuclear factor 4-alpha in perfluorooctanoic acid- and perfluorooctanesulfonic acid-induced hepatocellular dysfunction. Beggs KM, McGreal SR, McCarthy A, Gunewardena S, Lampe JN, Lau C, Apte U. Toxicol Appl Pharmacol; 2016 Aug 01; 304():18-29. PubMed ID: 27153767 [Abstract] [Full Text] [Related]
12. Developmental toxicity of perfluorooctane sulfonate (PFOS) is not dependent on expression of peroxisome proliferator activated receptor-alpha (PPAR alpha) in the mouse. Abbott BD, Wolf CJ, Das KP, Zehr RD, Schmid JE, Lindstrom AB, Strynar MJ, Lau C. Reprod Toxicol; 2009 Jun 01; 27(3-4):258-265. PubMed ID: 18595657 [Abstract] [Full Text] [Related]
13. Impairment of bile acid metabolism by perfluorooctanoic acid (PFOA) and perfluorooctanesulfonic acid (PFOS) in human HepaRG hepatoma cells. Behr AC, Kwiatkowski A, Ståhlman M, Schmidt FF, Luckert C, Braeuning A, Buhrke T. Arch Toxicol; 2020 May 01; 94(5):1673-1686. PubMed ID: 32253466 [Abstract] [Full Text] [Related]
14. Comparison of in vitro cytotoxicity, estrogenicity and anti-estrogenicity of triclosan, perfluorooctane sulfonate and perfluorooctanoic acid. Henry ND, Fair PA. J Appl Toxicol; 2013 Apr 01; 33(4):265-72. PubMed ID: 21935973 [Abstract] [Full Text] [Related]
15. Exposure to perfluorinated compounds: in vitro study on thyroid cells. Coperchini F, Pignatti P, Lacerenza S, Negri S, Sideri R, Testoni C, de Martinis L, Cottica D, Magri F, Imbriani M, Rotondi M, Chiovato L. Environ Sci Pollut Res Int; 2015 Feb 01; 22(3):2287-94. PubMed ID: 25182428 [Abstract] [Full Text] [Related]
16. In vitro characterization of the immunotoxic potential of several perfluorinated compounds (PFCs). Corsini E, Sangiovanni E, Avogadro A, Galbiati V, Viviani B, Marinovich M, Galli CL, Dell'Agli M, Germolec DR. Toxicol Appl Pharmacol; 2012 Jan 15; 258(2):248-55. PubMed ID: 22119708 [Abstract] [Full Text] [Related]
17. Investigation of the Effects of Perfluorooctanoic Acid (PFOA) and Perfluorooctane Sulfonate (PFOS) on Apoptosis and Cell Cycle in a Zebrafish (Danio rerio) Liver Cell Line. Cui Y, Liu W, Xie W, Yu W, Wang C, Chen H. Int J Environ Res Public Health; 2015 Dec 09; 12(12):15673-82. PubMed ID: 26690195 [Abstract] [Full Text] [Related]
18. Distributions of perfluorooctanoic acid (PFOA) and perfluorooctane sulfonate (PFOS) in Japan and their toxicities. Nakayama S, Harada K, Inoue K, Sasaki K, Seery B, Saito N, Koizumi A. Environ Sci; 2005 Dec 09; 12(6):293-313. PubMed ID: 16609670 [Abstract] [Full Text] [Related]
19. Effects of perfluorooctanoic acid and perfluorooctane sulfonate on acute toxicity, superoxide dismutase, and cellulase activity in the earthworm Eisenia fetida. Yuan Z, Zhang J, Zhao L, Li J, Liu H. Environ Sci Pollut Res Int; 2017 Aug 09; 24(22):18188-18194. PubMed ID: 28634796 [Abstract] [Full Text] [Related]
20. Immunotoxicity mechanisms of perfluorinated compounds PFOA and PFOS. Liang L, Pan Y, Bin L, Liu Y, Huang W, Li R, Lai KP. Chemosphere; 2022 Mar 09; 291(Pt 2):132892. PubMed ID: 34780734 [Abstract] [Full Text] [Related] Page: [Next] [New Search]